MedPath

Investigating the effect of caffeine on cognitive and motor responses

Phase 3
Conditions
Cognitive and motor responses of the central nervous system.
Registration Number
IRCT20230318057752N2
Lead Sponsor
Fasa University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
75
Inclusion Criteria

Healthy people with informed consent to participate in the study

Exclusion Criteria

Any reaction or sensitivity to caffeine
Addicted to drugs, alcohol and tobacco
Consuming coffee and painkillers containing caffeine, nerve agents, tea and drinks that can affect the tests, from 48 hours before
Cognitive disorders
Mental disorders
Cardiovascular diseases
Neurological disorders
Thyroid disorders
Mouth or mucous membrane diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum caffeine level. Timepoint: 10, 30 and 60 minutes after receiving caffeine. Method of measurement: ELISA.;Selective attention capacity. Timepoint: Before receiving caffeine, 10, 30 and 60 minutes after receiving caffeine. Method of measurement: Using computer tests.;Selective processing speed. Timepoint: Before receiving caffeine, 10, 30 and 60 minutes after receiving caffeine. Method of measurement: Using computer tests.;Short-Term Memory. Timepoint: Before receiving caffeine, 10, 30 and 60 minutes after receiving caffeine. Method of measurement: Using computer tests.;Hand Eye Coordination. Timepoint: Before receiving caffeine, 10, 30 and 60 minutes after receiving caffeine. Method of measurement: Using computer tests.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath